Korsana Biosciences (KRSA) Earnings
Korsana Biosciences reported on November 5, 2026: EPS of -3.19 against -0.78 expected, a miss.
Summary
In the quarter ended September 2026, Korsana Biosciences had revenue of —, and diluted EPS of -3.19.
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Last | Thu Nov 5, 2026 | — | -0.78 | -3.19 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 2
| Company | Date | Time |
|---|---|---|
| Apple Inc AAPL | Mon Nov 2 | Reported |
| Advanced Micro Devices Inc AMD | Tue Nov 3 | Reported |
| Palantir Technologies Inc. PLTR | Mon Nov 2 | Reported |
| Toyota Motor Corporation ADR TM | Wed Nov 4 | Reported |
| Amgen Inc AMGN | Tue Nov 3 | Reported |
| Arista Networks ANET | Tue Nov 3 | Reported |
| McDonald’s Corporation MCD | Wed Nov 4 | Reported |
| Shopify Inc SHOP | Tue Nov 3 | Reported |
Quarterly results
The last 12 quarters from Korsana Biosciences's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | — | — | -3.19 | — | — | 2026-11-05 |
| Jun 30, 2026 | $0 | — | -0.41 | — | — | 2026-08-04 |
| Mar 31, 2026 | $0 | — | -0.76 | — | — | 2026-05-12 |
| Dec 31, 2025 | $1M | -43.2% | — | — | -483.0% | 2026-03-30 |
| Sep 30, 2025 | $875,000 | +351.0% | -39.49 | — | -2.5% | 2025-11-12 |
| Jun 30, 2025 | $93,000 | — | -0.11 | — | -1797.8% | 2025-08-05 |
| Mar 31, 2025 | $81,000 | — | -0.56 | — | -1798.8% | 2025-05-06 |
| Dec 31, 2024 | $2M | — | — | — | 27.8% | 2025-03-04 |
| Sep 30, 2024 | $194,000 | — | -0.29 | — | -581.4% | 2024-11-14 |
| Jun 30, 2024 | $0 | — | -0.53 | — | — | 2024-08-07 |
| Mar 31, 2024 | $0 | — | -0.62 | — | — | 2024-05-07 |
| Dec 31, 2023 | $0 | — | — | — | — | 2024-03-05 |
Questions about Korsana Biosciences
Did Korsana Biosciences beat earnings estimates?
In its report on November 5, 2026, Korsana Biosciences missed the EPS estimate: -3.19 reported against -0.78 expected.
How did Korsana Biosciences do last quarter?
In the quarter ended September 2026, Korsana Biosciences had revenue of —, and diluted EPS of -3.19.
From Korsana Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.